Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data

Journal of Clinical Epidemiology

Volumn 50, Issue 6, 1997, Pages 725-733

  Newschaffer, Craig J ^a,b,d   Bush, Trudy L ^b,c   Penberthy, Lynne T ^b,c  

^a SAINT LOUIS UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Administrative data; Aged; Agreement; Breast neoplasms; Comorbidity

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; COMORBIDITY; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MEDICARE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RELIABILITY; SURVIVAL RATE; UNITED STATES;

AGED; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; MEDICAL RECORD LINKAGE; MEDICARE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; REPRODUCIBILITY OF RESULTS; RISK; SURVIVAL RATE; UNITED STATES; VIRGINIA;

EID: 0030805637     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(97)00050-4     Document Type: Article

References (35)

1. 1. Feinstein AR, Schimpff CR, Hull EW. A re-appraisal of staging and therapy for patients with cancer of the rectum. Arch Intern Med 1975; 135: 1441-1453.
2. 2. Feinstein AR, Schimpff CR, Andrews JF, et al. Cancer of the larynx: A new staging system and a re-appraisal of prognosis and treatment. J Chron Dis 1977; 30: 277-305.
3. 3. Wells CK, Stoller JK, Feinstein AR, et al. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984; 144: 2004-2009.
4. 4. Clemens JD, Feinstein AR, Holabird N, et al. A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer. J Cron Dis 1986; 39: 913-928.
5. 5. Feinstein AR, Wells K. A clinical-severity staging system for patients with lung cancer. Medicine 1990; 69: 1-33.
6. 6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987; 40: 373-383.
7. 7. Satariano WA, Ragheb NE, Dupuis MH. Comorbidity in older women with breast cancer: An epidemiologic approach. In: Yancik R, Yates R, Eds. Cancer in the Elderly: Approaches to Early Diagnosis and Treatment. New York: Springer Press; 1989: 71-107.
8. 8. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104-110.
9. 9. Bergman L, Dekker G, van Kerkoff EHM, et al. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treatment 1991; 18: 189-198.
10. 10. Satariano WA. Comorbidity and functional status in older women with breast cancer: Implications for screening, treatment, and prognosis. J Gerentol 1992; 47: 24-31.
11. 11. Mandellblatt JS, Wheat ME, Monac M, et al. Breast cancer screening for elderly women with and without comorbid conditions. Ann Int Med 1992; 116: 722-730.
12. 12. Costanza ME. Issues in breast cancer screening in older women. Cancer 1994; 74: S2009-2015.
13. 13. Guralnik JM, LaCroix AZ, Everett DF, Kovar MG. Aging in the eighties: The prevalance and comorbidity and its association with disability. Advance Data 1989; 170: 1-8.
14. 14. Fisher ES, Baron JA, Malenka DJ, et al. Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Public Health 1990; 80: 1487-1490.
15. 15. Fisher ES, Whaley FS, Krushat M, et al. The accuracy of Medicare's hospital claims data: Progress has been made, but problems remain. Am J Public Health 1992; 82: 243-248.
16. 16. Jencks SF. Accuracy in recorded diagnoses (Editorial). JAMA 1992; 267: 2338-2339.
17. 17. Lauderdale DS, Furner SE, Miles TP, et al. Epidemiologic uses of Medicare data. Epidemiol Rev 1993; 15: 319-327.
18. 18. Jencks SF, Williams DK, Kay TL. Assessing hospital-associated deaths from discharge data. JAMA 1988; 260: 2240-2246.
19. 19. Hsia DC, Krushat WM, Fagan AB, Tebbutt JA, Kusserow RP. Accuracy of diagnostic coding for Medicare patients under the prospective payment system. New Engl J Med 1988; 318: 352-355.
20. 20. Malenka DJ, McLerran D, Roos N, Fisher ES, Wennberg JE. Using administrative data to describe casemix: A comparison with the medical record. J Clin Epidemiol 1994; 47: 1027-1032.
21. 21. Desch CE, Penberthy LP, Retchin SM, McClish D, Smith TJ, Hilner BE, Newschaffer CJ, MacDonald K, Whittemore M. Evaluation of Practice Variations and Costs for Cancer. Final report prepared for AHCPR (Grant# R01 HS659-01A1). October 1994.
22. 22. Desch CD, Penberthy LP, Newschaffer CJ, et al. Factors that determine treatment for local and regional prostate cancer. Med Care. 1996; 34: 152-162.
23. 23. McBean AM, Babish JD, Warren JL. Determination of lung cancer incidence in the elderly using Medicare claims data. Am J Epidemiol 1993; 137: 226-234.
24. 24. Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes melitus. J Chron Dis 1974; 27: 387-404.
25. 25. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 1993; 46: 1075-1079.
26. 26. Shambaugh EW, Weiss MA, Axtell LM, Eds. Summary Staging Guide: Cancer Surveillance, Epidemiology, and End Results (SEER) Program. Bethesda, MD: Department of Health, Education, and Welfare; National Institutes of Health; 1977: 77-1448.
27. 27. Fleiss JL. Statistical Methods for Rates and Proportions. New York: John Wiley and Sons; 1981.
28. 28. Selvin S. Statistical Analysis of Epidemiologic Data. New York: Oxford University Press; 1991.
29. 29. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. New York, NY: John Wiley and Sons; 1995.
30. 30. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schif SF. Problems of comorbidity in mortality after prostatectomy. JAMA 1992; 267: 1077-1083.
31. 31. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980; 112: 564-569.
32. 32. Savitz DA, Baron AE. Estimating and correcting for confounder misclassification. Am J Epidemiol 1989; 129: 1062-1071.
33. 33. Brenner H. Bias due to non-differential misclassification of polytomous confounders. J Clin Epidemiol 1993; 46: 57-63.
34. 34. Wacholder S. When measurement errors correlate with truth: Surprising effects of nondifferential misclassification. Epidemiology 1994; 6: 157-161.
35. 35. Newschaffer CJ, Penberthy LP, Desch CD, Retchin S, Whittemore M. The effect of age and comorbidity on the treatment of non-metastatic breast cancer in elderly women. Arch Int Med 1996; 156: 85-90.